Positron emission tomography derived metrics in relapsed or refractory large B‐cell lymphoma with residual disease before autologous stem cell transplant

Authors: Cherng, Hua‐Jay J., Xu, Guofan, Feng, Lei, Steiner, Raphael, Fayad, Luis, Strati, Paolo, Nair, Ranjit, Nastoupil, Loretta J., Lee, Hun Ju, Neelapu, Sattva S., Flowers, Christopher R., Rodriguez, Maria, Wang, Michael, Hagemeister, Fredrick, Pinnix, Chelsea C., Ramdial, Jeremy, Srour, Samer, Nieto, Yago, Rezvani, Katayoun, Champlin, Richard, Kebriaei, Partow, Westin, Jason, Macapinlac, Homer A., Shpall, Elizabeth, Ahmed, Sairah

Source: British journal of haematology. 200(1):35-44

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100182461628.0x000001&indx=1&recIds=ETOCvdc_100182461628.0x000001

A phase 1/2 study of lenalidomide and obinutuzumab with CHOP for newly diagnosed DLBCL

Authors: Cherng, Hua-Jay J., Alig, Stefan K., Oki, Yasuhiro, Nastoupil, Loretta J., Fayad, Luis, Neelapu, Sattva S., Turturro, Francesco, Hagemeister, Fredrick, Craig, Alexander F. M., Macaulay, Charles W., Rodriguez, Maria Alma, Lee, Hun Ju, McDonnell, Timothy J., Flowers, Christopher R., Vega, Francisco, Green, Michael R., Feng, Lei, Kurtz, David M., Alizadeh, Ash A., Davis, R. Eric, Westin, Jason R.

Source: In Blood Advances 11 April 2023 7(7):1137-1145

A prospective study on early PET/CT scans during the first cycle of salvage chemotherapy for relapsed or refractory diffuse large B-cell lymphoma

Authors: Cherng, Hua-Jay J., Chuang, Hubert H., Steiner, Raphael, Fayad, Luis, Strati, Paolo, Nair, Ranjit, Hagemeister, Fredrick, Nastoupil, Loretta J., Lee, Hun Ju, Neelapu, Sattva S., Flowers, Christopher R., Samaniego, Felipe, Rodriguez, Maria, Macapinlac, Homer A., Feng, Lei, Westin, Jason

Source: Leukemia & lymphoma. 63(1):74-83

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100138755279.0x000001&indx=1&recIds=ETOCvdc_100138755279.0x000001

Risk assessment with low-pass whole-genome sequencing of cell-free DNA before CD19 CAR T-cell therapy for large B-cell lymphoma

Authors: Cherng, Hua-Jay J., Sun, Ryan, Sugg, Bryant, Irwin, Russell, Yang, Haopeng, Le, Cao Cuong, Deng, Qing, Fayad, Luis, Fowler, Nathan H., Parmar, Simrit, Steiner, Raphael, Hagemeister, Fredrick, Nair, Ranjit, Lee, Hun Ju, Rodriguez, Maria, Samaniego, Felipe, Iyer, Swaminathan P., Flowers, Christopher R., Wang, Linghua, Nastoupil, Loretta J., Neelapu, Sattva S., Ahmed, Sairah, Strati, Paolo, Green, Michael R., Westin, Jason

Source: Blood. 140(5):504-515

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100183235781.0x000001&indx=1&recIds=ETOCvdc_100183235781.0x000001

TP53‐altered chronic lymphocytic leukemia treated with firstline Bruton's tyrosine kinase inhibitor‐based therapy: A retrospective analysis

Authors: Cherng, Hua‐Jay J., Khwaja, Raamis, Kanagal‐Shamanna, Rashmi, Tang, Guilin, Burger, Jan, Thompson, Philip, Ferrajoli, Alessandra, Estrov, Zeev, Sasaki, Koji, Sampath, Deepa, Wang, Xuemei, Kantarjian, Hagop, Keating, Michael, Wierda, William G., Jain, Nitin

Source: American journal of hematology. 97(8):1005-1012

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100154857300.0x000001&indx=1&recIds=ETOCvdc_100154857300.0x000001

First-Line Therapy for Chronic Lymphocytic Leukemia: Bruton Tyrosine Kinase or BCL2 or Both?

Authors: Cherng, Hua-Jay J., Jain, Nitin

Source: In Hematology/Oncology Clinics of North America August 2021 35(4):725-738

Clinical and molecular characteristics and treatment patterns of adolescent and young adult patients with chronic lymphocytic leukaemia

Authors: Cherng, Hua‐Jay J., Jammal, Nadya, Paul, Shilpa, Wang, Xuemei, Sasaki, Koji, Thompson, Philip, Burger, Jan, Ferrajoli, Alessandra, Estrov, Zeev, O'Brien, Susan, Keating, Michael, Wierda, William G., Jain, Nitin

Source: British journal of haematology. 194(1):61-68

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100127373682.0x000001&indx=1&recIds=ETOCvdc_100127373682.0x000001

Why R-CHOP + X is not enough: lessons learned and next steps in the mission to improve frontline therapy for diffuse large B-cell lymphoma

Authors: Cherng, Hua-Jay J., Westin, Jason

Source: Leukemia & lymphoma. 62(6):1302-1312

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100121500681.0x000001&indx=1&recIds=ETOCvdc_100121500681.0x000001

Incidental Richter transformation in chronic lymphocytic leukemia patients during temporary interruption of ibrutinib

Authors: Hampel, Paul J. ^{*, *}, Cherng, Hua-Jay J. ^*, Call, Timothy G., Ding, Wei, Khanlari, Mahsa, McPhail, Ellen D., Miranda, Roberto N., Lin, Pei, Tawbi, Hussein A., Ferrajoli, Alessandra, Wierda, William G., Jain, Nitin, Parikh, Sameer A.

Source: In Blood Advances 22 September 2020 4(18):4508-4511

Interim PET/CT Result Is Not Predictive of Survival in Patients With MYC-rearranged Non–Burkitt Aggressive B-cell Lymphoma

Authors: Cherng, Hua-Jay J., Sargent, Rachel Lynn, Nasta, Sunita Dwivedy, Svoboda, Jakub, Schuster, Stephen J., Mato, Anthony R., Schrank-Hacker, April, Morrissette, Jennifer J.D., Landsburg, Daniel J.

Source: In Clinical Lymphoma, Myeloma and Leukemia October 2018 18(10):673-678

Circulating Tumor DNA in Diffuse Large B-Cell Lymphoma: from Bench to Bedside?

Authors: Cherng, Hua-Jay J., Herrera, Alex

Source: Current Treatment Options in Oncology; May2024, Vol. 25 Issue 5, p659-678, 20p

9 - Process and General Management of Patients Undergoing Chimeric Antigen Receptor Therapies

Authors: CHERNG, HUA-JAY J., MCGEE, KARA, HAWKINS, MISHA C., WESTIN, JASON R.

Source: In Manual of Hematopoietic Cell Transplantation and Cellular Therapies 2024:115-122

Measurable Residual Disease Monitoring in Lymphoma.

Authors: Cuzzo, Brian, Lipsky, Andrew, Cherng, Hua-Jay J.

Source: Current Hematologic Malignancy Reports; Dec2023, Vol. 18 Issue 6, p292-304, 13p

Metastatic lung adenocarcinoma mimicking Richter transformation in a patient with chronic lymphocytic leukemia

Authors: Cherng, Hua-Jay J., Jain, Nitin, Thakral, Beenu, Muzzafar, Tariq, Miranda, Roberto N., Tan, Dongfeng, Rashid, Asif, Kalhor, Neda, Hahn, Andrew W., Byers, Lauren A., Parseghian, Christine M., Ferrajoli, Alessandra, Pemmaraju, Naveen

Source: Leukemia research. 98

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100114988358.0x000001&indx=1&recIds=ETOCvdc_100114988358.0x000001

List of Contributors

Authors: Rahman, Zaid Abdel, Abutalib, Syed Ali, Afrough, Aimaz, Ahmed, Sairah, Al-Juhaishi, Taha, Alousi, Amin M, Alsfeld, Leonard C., Awan, Farrukh T., Azhar, Ahsan, Bashir, Qaiser, Brown, Brandon Douglas, Cao, Kai, Champlin, Richard E., Cherng, Hua-Jay J., Ciurea, Stefan O., Dabaja, Bouthaina, Daher, May, De Lima, Marcos, Dillard, Christen M., Fang, Penny, Viña, Marcelo A. Fernández, Ferreri, Christopher James, Furqan, Fateeha, Gagelmann, Nico, Geethakumari, Praveen Ramakrishnan, Ghanem, Sassine, Greenbaum, Uri, Gulbis, Alison M., Haider, Ali, Hamadani, Mehdi, Handy, Victoria Wehr, Hawkins, Misha C., Heredia, Ella J. Ariza, Hosing, Chitra, Im, Jin Seon, Jain, Nitin, Jallouk, Andrew P, Jankowski, Mika L., Kale, Brandon J., Kebriaei, Partow, Khalil, Lana, Khan, Irum, Khazal, Sajad, Kongtim, Piyanuch, Lin, Paul, Mahadeo, Kris M., Malek, Alexandre E, McGee, Kara, Mehta, Rohtesh S., Mulanovich, Victor Eduardo, Munshi, Pashna N., Nastoupil, Loretta J., Neelapu, Sattva S, Nieto, Yago, Olson, Amanda, Oran, Betul, Otegbeye, Folashade, Patel, Akshat Maneesh, Patel, Krina, Paul, Prince, Pemmaraju, Naveen, Popat, Uday R, Qazilbash, Muzaffar H., Rafei, Hind, Ragoonanan, Dristhi S, Ramdial, Jeremy L., Rezvani, Katayoun, Rodriguez, Ana Avila, Rondón, Gabriela, Saengboon, Supawee, Sanchez-Petitto, Gabriela, Shigle, Terri Lynn, Shpall, Elizabeth J., Srour, Samer A., Steiner, Raphael E., Stolar, Karen R., Strati, Paolo, Szewczyk, Nicholas A., Tanner, Mark R., Tang, Kevin, Thall, Peter F., Tummala, Sudhakar, Uzoka, Chukwuemeka, Wallis, Whitney D., Westin, Jason R., Wilson, Nathaniel R., Wu, Susan, Guevara, Eduardo Yepez, Zou, Jun

Source: In Manual of Hematopoietic Cell Transplantation and Cellular Therapies 2024:v-x

JAK1/2 Inhibition Modulates Key Markers of Lymphomagenesis in 9p24.1 Amplified Lymphoma, Priming for Enhanced Antigenicity

Authors: Tolu, Seda S., Piorczynski, Ted B., Pazos, Manuel, II, Estrella, Brian, Huang, Wenxuan, Ryu, Yun Kyoung, Cherng, Hua-Jay J., Pro, Barbara, Amengual, Jennifer E.

Source: In Blood 2 November 2023 142 Supplement 1:6118-6118

Methylated Whole Genome Cell-Free DNA Sequencing before Chimeric Antigen Receptor T-Cell Therapy for Large B-Cell Lymphoma Predicts Treatment Outcomes

Authors: Cherng, Hua-Jay J., Yang, Xiaojing, Yancey, Ryan, Gordillo, Christian A, Piorczynski, Ted B., Chan, Hei T., Ofori, Kenneth N., Bhagat, Govind, Califano, Andrea, Pro, Barbara, Booher, Keith, Amengual, Jennifer E., Reshef, Ran, Sina, Abu A. I.

Source: In Blood 2 November 2023 142 Supplement 1:4371-4371

The Effect of Preemptive Rituximab Treatment in Patients with EBV Viremia after Solid Organ Transplantation on the Development of Post-Transplant Lymphoproliferative Disorder

Authors: Orlando, Evelyn H., Gould, Patrick, Cuzzo, Brian, Ford, Maegan, Chen, Yuxuan, Sanjurjo, Alexander, May, Benjamin, Tsapepas, Demetra, Leeman-Neill, Rebecca J., Bhagat, Govind, Dube, Geoffrey, Morris, Heather, Arcasoy, Selim, Latif, Farhana, Martinez, Mercedes, Pereira, Marcus, Lipsky, Andrew H., Sawas, Ahmed, Reshef, Ran, Pro, Barbara, Cherng, Hua-Jay J., Amengual, Jennifer E.

Source: In Blood 2 November 2023 142 Supplement 1:990-990

Clonal Hematopoiesis Driven By Recurrent Somatic Mutations but Not with Recurrent Copy Number Alterations Is Associated with Inferior Outcomes in DLBCL after Induction Chemotherapy, but Not CAR19 Therapy

Authors: Boegeholz, Jan, Alig, Stefan K., Sworder, Brian, Schroers-Martin, Joseph, Macaulay, Charles ^*, Craig, Alexander F.M., Duehrsen, Ulrich, Hüttmann, Andreas, Westin, Jason, Cherng, Hua-Jay J., Miklos, David B., Frank, Matthew J, Diehn, Maximilian ^*, Kurtz, David M., Alizadeh, Ash A.

Source: In Blood 15 November 2022 140 Supplement 1:8609-8610

Retrospective Single-Institution Analysis of Patients with Chronic Lymphocytic Leukemia with TP53 alterations Treated First-Line with Bruton's Tyrosine Kinase Inhibitor-Based Therapy

Authors: Cherng, Hua-Jay J., Khwaja, Raamis, Kanagal-Shamanna, Rashmi, Burger, Jan A., Thompson, Philip A., Ferrajoli, Alessandra, Estrov, Zeev E., Sasaki, Koji, Sampath, Deepa, Tang, Guilin, Wang, Xuemei, Kantarjian, Hagop, Keating, Michael J., Wierda, William G., Jain, Nitin

Source: In Blood 23 November 2021 138 Supplement 1:394-394